These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1481542)

  • 1. [Non-drug therapy of ventricular tachycardia/ventricular fibrillation].
    Steinbach K; Frohner K; Hief C; Kaltenbrunner W; Nürnberg M; Podczeck A; Veit F
    Wien Med Wochenschr; 1992; 142(15-16):367-70. PubMed ID: 1481542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ventricular tachycardia and ventricular fibrillation. Diagnostic procedure for selection of patients for non-medicamentous therapeutic procedures].
    Schmidinger H
    Wien Med Wochenschr; 1992; 142(15-16):341-6. PubMed ID: 1481538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in antiarrhythmic therapy].
    Yamashita T
    Nihon Rinsho; 2009 Sep; 67(9):1811-20. PubMed ID: 19768921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ventricular fibrillation/tachycardia].
    Aizawa Y
    Nihon Rinsho; 2002 Jul; 60(7):1382-8. PubMed ID: 12136618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of ventricular arrhythmias.
    Anderson MH
    Br J Hosp Med; 1994 Sep 7-20; 52(5):204-9. PubMed ID: 7529627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with the implantable cardioverter defibrillator (ICD)].
    Jordaens LJ
    Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials of implantable defibrillators.
    Myerburg RJ; Castellanos A
    N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Implantable defibrillators in the management of malignant ventricular tachyarrhythmias. Experience at the Arrhythmia National Center].
    Asenjo R; Oyarzún R; González M; Morales P; Zamorano J; Brunet L; Morris R; Ortiz M
    Rev Med Chil; 1998 Jul; 126(7):803-13. PubMed ID: 9830773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.